Detected ·

Oranda Therapeutics

——

Oranda Therapeutics, a rare disease medicines platform expanding access across Europe, secured funding led by BVP alongside Integrated Finance Group (IFG). The company has secured its first marketing authorisation in Germany with European expansion underway and initial product launch planned for late 2026.

Amount
—
Stage
—
Event
Funding round
Detected
2026-05-07 12:12:11 UTC
Signal ID
5f080811-1c11-4575-b27a-9d9514bd9530

As the API returns it

{
  "id": "5f080811-1c11-4575-b27a-9d9514bd9530",
  "created_at": "2026-05-07T12:12:11.633105Z",
  "company_name": "Oranda Therapeutics",
  "company_website_url": "www.orandatherapeutics.com",
  "company_linkedin_url": "https://www.linkedin.com/company/oranda-therapeutics",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Oranda Therapeutics, a rare disease medicines platform expanding access across Europe, secured funding led by BVP alongside Integrated Finance Group (IFG). The company has secured its first marketing authorisation in Germany with European expansion underway and initial product launch planned for late 2026.*"
}

Latest rounds